Robert Ross Carter Oncology Institute, Inc. (TOI) insider trading activity

Robert Ross Carter is Chief Financial Officer of Oncology Institute, Inc.. Currently has a direct ownership of 235,174 shares of TOI, which is worth approximately $602,045. The most recent transaction as insider was on May 21, 2025, when has been sold 1,601 shares (Class A Common Stock) at a price of $2.67 per share, resulting in proceeds of $4,274. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 235K

0.68% 3M change

n/a 12M change

Total Value Held $602,045

Robert Ross Carter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 21 2025	SELL Sale (or disposition) back to the issuer	$4,274 $2.67 p/Share	1,601 Reduced 0.68%	235,174 Class A Common Stock
Mar 31 2025	BUY Grant, award, or other acquisition	-	197,368 Added 45.46%	236,775 Class A Common Stock
Mar 26 2025	BUY Open market or private purchase	$9,418 $1.04 p/Share	9,056 Added 18.69%	39,407 Common Stock
Mar 19 2025	SELL Sale (or disposition) back to the issuer	$1,023 $0.89 p/Share	1,150 Reduced 3.65%	30,351 Class A Common Stock
Jan 06 2025	SELL Sale (or disposition) back to the issuer	$87 $0.34 p/Share	258 Reduced 0.81%	31,501 Class A Common Stock
Nov 20 2024	SELL Sale (or disposition) back to the issuer	$32 $0.14 p/Share	235 Reduced 0.73%	31,759 Class A Common Stock

RRC

Robert Ross Carter

Chief Financial Officer

Cerritos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Value

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI

Account